MT Genex Statistics
Total Valuation
MT Genex has a market cap or net worth of JPY 3.69 billion. The enterprise value is 1.61 billion.
| Market Cap | 3.69B |
| Enterprise Value | 1.61B |
Important Dates
The last earnings date was Friday, February 6, 2026.
| Earnings Date | Feb 6, 2026 |
| Ex-Dividend Date | Mar 30, 2026 |
Share Statistics
MT Genex has 1.08 million shares outstanding. The number of shares has decreased by -0.03% in one year.
| Current Share Class | 1.08M |
| Shares Outstanding | 1.08M |
| Shares Change (YoY) | -0.03% |
| Shares Change (QoQ) | +0.11% |
| Owned by Insiders (%) | 5.48% |
| Owned by Institutions (%) | 2.42% |
| Float | 283,666 |
Valuation Ratios
The trailing PE ratio is 11.96.
| PE Ratio | 11.96 |
| Forward PE | n/a |
| PS Ratio | 0.83 |
| PB Ratio | 0.86 |
| P/TBV Ratio | 0.88 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 5.24 |
| EV / Sales | 0.36 |
| EV / EBITDA | 2.74 |
| EV / EBIT | 3.38 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.77, with a Debt / Equity ratio of 0.02.
| Current Ratio | 7.77 |
| Quick Ratio | 4.44 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.14 |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 7.40% and return on invested capital (ROIC) is 13.65%.
| Return on Equity (ROE) | 7.40% |
| Return on Assets (ROA) | 5.93% |
| Return on Invested Capital (ROIC) | 13.65% |
| Return on Capital Employed (ROCE) | 10.25% |
| Weighted Average Cost of Capital (WACC) | 4.24% |
| Revenue Per Employee | 33.25M |
| Profits Per Employee | 2.30M |
| Employee Count | 134 |
| Asset Turnover | 0.88 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, MT Genex has paid 192.00 million in taxes.
| Income Tax | 192.00M |
| Effective Tax Rate | 38.40% |
Stock Price Statistics
The stock price has increased by +31.73% in the last 52 weeks. The beta is 0.02, so MT Genex's price volatility has been lower than the market average.
| Beta (5Y) | 0.02 |
| 52-Week Price Change | +31.73% |
| 50-Day Moving Average | 3,488.70 |
| 200-Day Moving Average | 3,192.15 |
| Relative Strength Index (RSI) | 39.19 |
| Average Volume (20 Days) | 915 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, MT Genex had revenue of JPY 4.46 billion and earned 308.00 million in profits. Earnings per share was 286.26.
| Revenue | 4.46B |
| Gross Profit | 1.11B |
| Operating Income | 478.00M |
| Pretax Income | 500.00M |
| Net Income | 308.00M |
| EBITDA | 590.00M |
| EBIT | 478.00M |
| Earnings Per Share (EPS) | 286.26 |
Balance Sheet
The company has 2.16 billion in cash and 85.00 million in debt, with a net cash position of 2.07 billion or 1,925.17 per share.
| Cash & Cash Equivalents | 2.16B |
| Total Debt | 85.00M |
| Net Cash | 2.07B |
| Net Cash Per Share | 1,925.17 |
| Equity (Book Value) | 4.29B |
| Book Value Per Share | 3,987.49 |
| Working Capital | 4.17B |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 24.87%, with operating and profit margins of 10.73% and 6.91%.
| Gross Margin | 24.87% |
| Operating Margin | 10.73% |
| Pretax Margin | 11.22% |
| Profit Margin | 6.91% |
| EBITDA Margin | 13.24% |
| EBIT Margin | 10.73% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 40.00, which amounts to a dividend yield of 1.16%.
| Dividend Per Share | 40.00 |
| Dividend Yield | 1.16% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.03% |
| Shareholder Yield | 1.18% |
| Earnings Yield | 8.36% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on September 27, 2017. It was a reverse split with a ratio of 0.1.
| Last Split Date | Sep 27, 2017 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
MT Genex has an Altman Z-Score of 4.93 and a Piotroski F-Score of 5.
| Altman Z-Score | 4.93 |
| Piotroski F-Score | 5 |